There are some sectors where large players have an edge, because the nature of the business is such that there are phases where ability to stay in the game and cash on the balance sheet matter most. When the tide turns in favor of that sector, these large companies are able to make most of it. One sector which has gone through a phase of realignment of business and readjustment of valuations for many years and has once again come in limelight is the pharma space. Right from ability to deal with USFDA, not rely just on product segment to how to deal with uncertainty of supply chain which is dependent on China, Indian pharma companies have come a long way.
Stocks to buy today: Domestic brokerages have come out with research reports on select stocks namely Star Health and Allied Insurance Company, Surya Roshni, Shriram Finance and Syngene International. Watch this Business Today Visual Story to check stocks to buy or sell on May 2, 2023.
Kiran Mazumdar’s contract research and manufacturing firm Syngene International has been on a roller coaster ride on Dalal Street in the ongoing calendar year.